These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4687825)

  • 1. [Manufacturing delayed action tablet using sugar cane wax].
    Orbán E; Isaura LV
    Acta Pharm Hung; 1973 Jan; 43(1):9-13. PubMed ID: 4687825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
    Chalabala M; Starha L
    Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the accuracy of different types of dissolution rate methods.
    Bolhuis GK; Lerk CF; Zuurman K
    Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on sugar coating. II. Shape of core tablet for sugar coating].
    Hasegawa K; Ida T; Saika K; Utsumi I
    Yakugaku Zasshi; 1965 Sep; 85(9):796-9. PubMed ID: 5893165
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 8. Coating of pharmaceuticals by phase separation of cellulose derivatives: preparation and in-vitro release.
    Khalil SH; el-Gamal SS
    Pharmazie; 1973 Jun; 28(6):385-8. PubMed ID: 4726397
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption of the drug-contents of enteric-coated tablets].
    Tikkanen R
    Nord Med; 1967 Nov; 78(47):1564-7. PubMed ID: 6075282
    [No Abstract]   [Full Text] [Related]  

  • 13. Solid oral dosage forms.
    Helliwell M; Taylor D
    Prof Nurse; 1993 Feb; 8(5):313-7. PubMed ID: 8451252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology.
    Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T
    Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compression-coated doughnut-shaped tablet design for zero-order sustained release.
    Sundy E; Danckwerts MP
    Eur J Pharm Sci; 2004 Aug; 22(5):477-85. PubMed ID: 15265518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and examination of the vitro releasing of pH-dependent kuijiekang tablet for colon-specific delivery].
    Li RZ; Liao HW; Chen FY
    Zhong Yao Cai; 2007 Aug; 30(8):1025-7. PubMed ID: 18074860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tablets in stool? A common problem!].
    Schuerch LV; Nyfeler J; Holder G; Surber C; Haefeli WE
    Schweiz Med Wochenschr; 1999 May; 129(17):670-3. PubMed ID: 10407938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tableting research and technology.
    Cooper J; Rees JE
    J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.